These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 25146511)

  • 1. [The prevalence and relevant factors of hyperglycemia in AIDS patients receiving antiretroviral therapy in a single center].
    Cheng W; Wu Y; Dou Z; Ma Y; Sun L; Li Z; Wu H; Zhang F
    Zhonghua Nei Ke Za Zhi; 2014 Jun; 53(6):446-9. PubMed ID: 25146511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A retrospective cohort study on survival time of AIDS death cases receiving Antiretroviral Therapy and related factors].
    Hao L; Zhu X; Wang G; Lin B; Qian Y; Tao X; Hu J; Yang X; Kang D
    Zhonghua Yu Fang Yi Xue Za Zhi; 2014 Jun; 48(6):466-70. PubMed ID: 25219434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and Associated Risk Factors of Hyperglycemia and Diabetes Mellitus Among HIV Positive Patients in Tehran, Iran.
    Rasoolinejad M; Najafi E; Hadadi A; Najafi M; Kalantari S; Moradmand-Badie B; Tayeri K; SeyedAlinaghi S
    Infect Disord Drug Targets; 2019; 19(3):304-309. PubMed ID: 30039766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Study on the prevalence of loss to follow-up and risk factors among human immunodeficiency virus (HIV)/acquired immunodeficiency syndrome (AIDS) patients in Baoshan city, Yunnan province].
    Huang D; Zheng W; Yang J; Li Y; Hu A; Xu Z
    Zhonghua Yu Fang Yi Xue Za Zhi; 2014 Aug; 48(8):688-92. PubMed ID: 25388464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Survival analysis on AIDS patients undergoing antiretroviral treatment, Liangshan prefecture, Sichuan province].
    Zhang G; Gong Y; Wang Q; Liao Q; Yu G; Wang J; Wang K; Yin B; Xiao L; Li Y; Liu Z
    Zhonghua Liu Xing Bing Xue Za Zhi; 2014 Dec; 35(12):1329-32. PubMed ID: 25623448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Study on the situation of antiretroviral therapy against HIV/AIDS in Henan province based on the CD4+ T cells count and virus load].
    Liu J; Cui WG; Sun GQ; Zhu XP; Tian SA; Sun DY; Yang WJ; Li N; Zhu Q; Wang Z
    Zhonghua Liu Xing Bing Xue Za Zhi; 2010 Sep; 31(9):1013-6. PubMed ID: 21162867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of treatment outcomes for patients on first-line regimens in US President's Emergency Plan for AIDS Relief (PEPFAR) clinics in Uganda: predictors of virological and immunological response from RV288 analyses.
    Crawford KW; Wakabi S; Magala F; Kibuuka H; Liu M; Hamm TE
    HIV Med; 2015 Feb; 16(2):95-104. PubMed ID: 25124078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of hyperglycemia among adults with newly diagnosed HIV/AIDS in China.
    Shen Y; Wang Z; Liu L; Zhang R; Zheng Y; Lu H
    BMC Infect Dis; 2013 Feb; 13():79. PubMed ID: 23394285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Survival analysis of AIDS patients of 15 years or above years old after initiation antiretroviral treatment in Henan province during 2005 to 2014].
    Yang W; Fan P; Liang Y; Nie Y; Li N; Sun D; Zhu Q; Wang Z
    Zhonghua Yu Fang Yi Xue Za Zhi; 2015 Dec; 49(12):1061-6. PubMed ID: 26887300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intestinal parasitic infections and its association with undernutrition and CD4 T cell levels among HIV/AIDS patients on HAART in Butajira, Ethiopia.
    Gedle D; Kumera G; Eshete T; Ketema K; Adugna H; Feyera F
    J Health Popul Nutr; 2017 May; 36(1):15. PubMed ID: 28506307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of baseline CD4(+) T cell counts on the efficacy of nevirapine-based highly active antiretroviral therapy in Chinese HIV/AIDS patients: a prospective, multicentric study.
    Liu ZY; Guo FP; Han Y; Qiu ZF; Zuo LY; Li YL; Li TS
    Chin Med J (Engl); 2009 Oct; 122(20):2497-502. PubMed ID: 20079166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Analysis of the five-year effectiveness of highly active antiretroviral therapy among 200 HIV/AIDS patients in Jiangsu province].
    Qiu T; Ding P; Liu X; Guo H; Fu G; Xu X; Huan X; Yang H
    Zhonghua Yu Fang Yi Xue Za Zhi; 2014 Nov; 48(11):947-52. PubMed ID: 25582363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics, determinants, and clinical relevance of CD4 T cell recovery to <500 cells/microL in HIV type 1-infected individuals receiving potent antiretroviral therapy.
    Kaufmann GR; Furrer H; Ledergerber B; Perrin L; Opravil M; Vernazza P; Cavassini M; Bernasconi E; Rickenbach M; Hirschel B; Battegay M;
    Clin Infect Dis; 2005 Aug; 41(3):361-72. PubMed ID: 16007534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive factors for immunological and virological endpoints in Thai patients receiving combination antiretroviral treatment.
    Srasuebkul P; Ungsedhapand C; Ruxrungtham K; Boyd MA; Phanuphak P; Cooper DA; Law MG
    HIV Med; 2007 Jan; 8(1):46-54. PubMed ID: 17305932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Study on the mortality and risk factors among HIV/AIDS patients receiving antiretroviral therapy in Xinjiang Uygur Autonomous Region].
    Ni M; Chen X; Hu X; Ma Y
    Zhonghua Yu Fang Yi Xue Za Zhi; 2014 Nov; 48(11):953-8. PubMed ID: 25582364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Survival analysis of the AIDS patients under 14 years of age and receiving antiretroviral treatment in Henan province from 2003 to 2014].
    Sun D; Yang W; Ma Y; Wang Q; Liu J; Fan P; Li N; Zhu Q; Wang Z
    Zhonghua Yu Fang Yi Xue Za Zhi; 2015 Aug; 49(8):700-4. PubMed ID: 26733028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunologic response to antiretroviral therapy in hepatitis C virus-coinfected adults in a population-based HIV/AIDS treatment program.
    Braitstein P; Zala C; Yip B; Brinkhof MW; Moore D; Hogg RS; Montaner JS
    J Infect Dis; 2006 Jan; 193(2):259-68. PubMed ID: 16362890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short-term risk of AIDS or death in people infected with HIV-1 before antiretroviral therapy in South Africa: a longitudinal study.
    Badri M; Lawn SD; Wood R
    Lancet; 2006 Oct; 368(9543):1254-9. PubMed ID: 17027731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interruption of antiretroviral treatment in HIV-infected patients with preserved immune function is associated with a low rate of clinical progression: a prospective study by AIDS Clinical Trials Group 5170.
    Skiest DJ; Su Z; Havlir DV; Robertson KR; Coombs RW; Cain P; Peterson T; Krambrink A; Jahed N; McMahon D; Margolis DM;
    J Infect Dis; 2007 May; 195(10):1426-36. PubMed ID: 17436222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eosinophilic folliculitis: before and after the introduction of antiretroviral therapy.
    Rajendran PM; Dolev JC; Heaphy MR; Maurer T
    Arch Dermatol; 2005 Oct; 141(10):1227-31. PubMed ID: 16230559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.